Article metrics
Other content recommended for you
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- ‘Is it better not to know certain things?’: views of women who have undergone non-invasive prenatal testing on its possible future applications
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection
- Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study